Jordi Clarimón

32.0k total citations
122 papers, 4.9k citations indexed

About

Jordi Clarimón is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Jordi Clarimón has authored 122 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Physiology, 51 papers in Neurology and 44 papers in Molecular Biology. Recurrent topics in Jordi Clarimón's work include Alzheimer's disease research and treatments (53 papers), Parkinson's Disease Mechanisms and Treatments (34 papers) and Amyotrophic Lateral Sclerosis Research (17 papers). Jordi Clarimón is often cited by papers focused on Alzheimer's disease research and treatments (53 papers), Parkinson's Disease Mechanisms and Treatments (34 papers) and Amyotrophic Lateral Sclerosis Research (17 papers). Jordi Clarimón collaborates with scholars based in Spain, United States and United Kingdom. Jordi Clarimón's co-authors include Alberto Lleó, Rafael Blesa, Juan Fortea, Daniel Alcolea, Andrew Singleton, Jordi Pegueroles, Teresa Gómez‐Isla, Cristina Guardia‐Laguarta, Martí Colom‐Cadena and Jaume Bertranpetit and has published in prestigious journals such as Neuron, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jordi Clarimón

121 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jordi Clarimón Spain 41 2.2k 1.8k 1.5k 891 836 122 4.9k
Rita Guerreiro United Kingdom 40 2.6k 1.2× 1.9k 1.0× 1.8k 1.2× 772 0.9× 1.7k 2.1× 130 5.6k
Joanne Wuu United States 48 1.7k 0.8× 1.9k 1.1× 1.7k 1.2× 2.0k 2.2× 746 0.9× 107 6.6k
Dominique Campion France 45 3.2k 1.5× 1.4k 0.8× 2.7k 1.8× 1.2k 1.4× 813 1.0× 164 6.8k
Jordi Pérez‐Tur Spain 37 3.5k 1.6× 1.7k 0.9× 2.2k 1.5× 1.3k 1.4× 994 1.2× 91 5.6k
Caroline Graff Sweden 40 3.2k 1.4× 730 0.4× 3.1k 2.1× 883 1.0× 825 1.0× 159 6.5k
Kristel Sleegers Belgium 49 4.2k 1.9× 1.6k 0.9× 2.9k 2.0× 904 1.0× 1.4k 1.6× 135 7.4k
Yuko Saito Japan 44 2.8k 1.3× 2.9k 1.6× 2.0k 1.4× 1.5k 1.7× 1.6k 1.9× 191 6.6k
Stuart Pickering‐Brown United Kingdom 43 3.2k 1.4× 4.5k 2.5× 2.1k 1.4× 929 1.0× 1.5k 1.8× 111 6.6k
Hans Kretzschmar Germany 18 2.0k 0.9× 786 0.4× 1.3k 0.9× 724 0.8× 796 1.0× 28 3.8k
Selina Wray United Kingdom 33 2.4k 1.1× 1.0k 0.6× 2.1k 1.4× 1.2k 1.3× 1.0k 1.2× 75 4.7k

Countries citing papers authored by Jordi Clarimón

Since Specialization
Citations

This map shows the geographic impact of Jordi Clarimón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Clarimón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Clarimón more than expected).

Fields of papers citing papers by Jordi Clarimón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordi Clarimón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Clarimón. The network helps show where Jordi Clarimón may publish in the future.

Co-authorship network of co-authors of Jordi Clarimón

This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Clarimón. A scholar is included among the top collaborators of Jordi Clarimón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Clarimón. Jordi Clarimón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gasca‐Salas, Carmen, Rafael Rodríguez‐Rojas, Beatriz Fernández‐Rodríguez, et al.. (2025). Apolipoprotein E genotypes and amyloid burden associated with cognitive decline in non-demented Parkinson's disease patients: A preliminary analysis. Journal of the Neurological Sciences. 473. 123510–123510. 1 indexed citations
2.
Dols‐Icardo, Oriol, Víctor Montal, Sònia Sirisi, et al.. (2020). Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurology Neuroimmunology & Neuroinflammation. 7(5). 57 indexed citations
3.
Cervera‐Carles, Laura, Oriol Dols‐Icardo, Laura Molina‐Porcel, et al.. (2020). Assessing circular RNAs in Alzheimer's disease and frontotemporal lobar degeneration. Neurobiology of Aging. 92. 7–11. 36 indexed citations
4.
Berthier, Marcelo L., Guadalupe Dávila, Jordi Clarimón, et al.. (2020). Developmental Dynamic Dysphasia: Are Bilateral Brain Abnormalities a Signature of Inefficient Neural Plasticity?. Frontiers in Human Neuroscience. 14. 73–73. 7 indexed citations
5.
Belbin, Olivia, Desheng Xu, María Carmona‐Iragui, et al.. (2020). Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer’s disease-related inhibitory circuit dysfunction in adults with Down syndrome. Molecular Neurodegeneration. 15(1). 46–46. 24 indexed citations
6.
Aguilar, L., Cinta Lleixà, Andrea Cortese, et al.. (2019). Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy. PLoS ONE. 14(2). e0212647–e0212647. 2 indexed citations
7.
Ramos‐Campoy, Oscar, Oriol Grau‐Rivera, Anna Antonell, et al.. (2018). Systematic Screening of Ubiquitin/p62 Aggregates in Cerebellar Cortex Expands the Neuropathological Phenotype of the C9orf72 Expansion Mutation. Journal of Neuropathology & Experimental Neurology. 77(8). 703–709. 21 indexed citations
8.
Fissolo, Nicolás, Laura Cervera‐Carles, Alberto Lleó, et al.. (2018). Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis. Multiple Sclerosis Journal. 25(11). 1535–1538. 9 indexed citations
9.
Alcolea, Daniel, Eduard Vilaplana, Marc Suárez‐Calvet, et al.. (2017). CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration. Neurology. 89(2). 178–188. 92 indexed citations
10.
Querol‐Vilaseca, Marta, Martí Colom‐Cadena, Jordi Pegueroles, et al.. (2017). YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies. Journal of Neuroinflammation. 14(1). 118–118. 102 indexed citations
11.
Spataro, Nino, Laura Cervera‐Carles, Roger Anglada, et al.. (2016). Detection of genomic rearrangements from targeted resequencing data in Parkinson's disease patients. Movement Disorders. 32(1). 165–169. 15 indexed citations
12.
Brás, José, Ruth Djaldetti, Simon Mead, et al.. (2016). Exome sequencing in a consanguineous family clinically diagnosed with early-onset Alzheimer's disease identifies a homozygous CTSF mutation. Neurobiology of Aging. 46. 236.e1–236.e6. 18 indexed citations
13.
Suárez‐Calvet, Marc, Valle Camacho, Beatriz Gómez‐Ansón, et al.. (2014). Early Cerebellar Hypometabolism in Patients With Frontotemporal Dementia Carrying the C9orf72 Expansion. Alzheimer Disease & Associated Disorders. 29(4). 353–356. 6 indexed citations
14.
Dols‐Icardo, Oriol, Marc Suárez‐Calvet, Isabel de la Torre Díez, et al.. (2012). Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia. Neurobiology of Aging. 33(8). 1851.e17–1851.e19. 11 indexed citations
15.
Colom‐Cadena, Martí, Ellen Gelpí, María José Martí, et al.. (2012). MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies. Neurobiology of Aging. 34(3). 936–942. 43 indexed citations
16.
Fortea, Juan, Albert Lladó, Jordi Clarimón, et al.. (2011). PICOGEN: Five years experience with a genetic counselling program for dementia. SHILAP Revista de lepidopterología. 26(3). 143–149. 18 indexed citations
17.
Setó‐Salvia, Núria, Jordi Clarimón, Javier Pagonabarraga, et al.. (2011). Dementia Risk in Parkinson Disease. Archives of Neurology. 68(3). 359–64. 108 indexed citations
18.
Gómez‐Isla, Teresa, Rafael Blesa, Merçé Boada, et al.. (2008). A Randomized, Double-blind, Placebo Controlled-trial of Triflusal in Mild Cognitive Impairment. Alzheimer Disease & Associated Disorders. 22(1). 21–29. 43 indexed citations
19.
Clarimón, Jordi, Aida M. Andrés, Jaume Bertranpetit, & David Comas. (2004). Comparative Analysis of Alu Insertion Sequences in the APP 5′ FlankingRegion in Humans and Other Primates. Journal of Molecular Evolution. 58(6). 722–731. 4 indexed citations
20.
Clarimón, Jordi, Jaume Bertranpetit, Merçé Boada, Lluís Tárraga, & David Comas. (2003). HSP70-2 (HSPA1B) is Associated with Noncognitive Symptoms in Late-Onset Alzheimer's Disease. Journal of Geriatric Psychiatry and Neurology. 16(3). 146–150. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rita Guerreiro Breakdown of academic impact, for papers by Joanne Wuu Breakdown of academic impact, for papers by Dominique Campion Breakdown of academic impact, for papers by Jordi Pérez‐Tur Breakdown of academic impact, for papers by Caroline Graff Breakdown of academic impact, for papers by Kristel Sleegers Breakdown of academic impact, for papers by Yuko Saito Breakdown of academic impact, for papers by Stuart Pickering‐Brown Breakdown of academic impact, for papers by Hans Kretzschmar Breakdown of academic impact, for papers by Selina Wray
Rankless by CCL
2026